T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
$2.5B |
| 2 |
Kenvue
KVUE
|
$1.3B |
| 3 |
Halliburton
HAL
|
$1.16B |
| 4 |
Charles Schwab
SCHW
|
$836M |
| 5 |
Boeing
BA
|
$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.52B |
| 2 |
Apple
AAPL
|
$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
$1.47B |
| 5 |
Intuit
INTU
|
$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Tyler Technologies
TYL
$24.2B
| $139M | 0.02% |
360,255
+19,399
| +6% | +$7.49M |
|
452
Vornado Realty Trust
VNO
$7.93B
| $138M | 0.02% |
6,089,317
+200,135
| +3% | +$4.54M |
|
453
Weatherford International
WFRD
$4.49B
| $137M | 0.02% |
1,520,822
+601,257
| +65% | +$54.3M |
|
454
Main Street Capital
MAIN
$5.95B
| $137M | 0.02% |
3,363,810
-40,348
| -1% | -$1.64M |
|
455
AerCap
AER
$22B
| $136M | 0.02% |
2,167,206
-78,091
| -3% | -$4.89M |
|
456
Enbridge
ENB
$105B
| $135M | 0.02% |
4,079,250
+1,845,918
| +83% | +$61.3M |
|
457
Republic Services
RSG
$71.7B
| $133M | 0.02% |
936,610
-8,825
| -0.9% | -$1.26M |
|
458
Ventyx Biosciences
VTYX
$180M
| $133M | 0.02% |
3,826,555
-122,738
| -3% | -$4.26M |
|
459
Neurocrine Biosciences
NBIX
$14.3B
| $133M | 0.02% |
1,179,650
-150,178
| -11% | -$16.9M |
|
460
Atmos Energy
ATO
$26.7B
| $132M | 0.02% |
1,247,209
-18,930
| -1% | -$2.01M |
|
461
Scholastic
SCHL
$654M
| $131M | 0.02% |
3,440,691
-634,475
| -16% | -$24.2M |
|
462
Immunocore
IMCR
$1.87B
| $131M | 0.02% |
2,521,284
+97,864
| +4% | +$5.08M |
|
|
SGEN
463
DELISTED
Seagen Inc. Common Stock
SGEN
| $130M | 0.02% |
612,737
-11,566
| -2% | -$2.45M |
|
464
Verra Mobility
VRRM
$3.97B
| $128M | 0.02% |
6,868,733
-521,635
| -7% | -$9.75M |
|
465
Norwegian Cruise Line
NCLH
$11.6B
| $128M | 0.02% |
7,743,757
+7,171,036
| +1,252% | +$118M |
|
466
Mettler-Toledo International
MTD
$26.9B
| $127M | 0.02% |
115,045
-2,966
| -3% | -$3.29M |
|
467
Lockheed Martin
LMT
$108B
| $127M | 0.02% |
311,331
+6,839
| +2% | +$2.8M |
|
468
Structure Therapeutics
GPCR
$1.27B
| $127M | 0.02% |
2,513,563
+740,213
| +42% | +$37.3M |
|
469
Arthur J. Gallagher & Co
AJG
$76.7B
| $126M | 0.02% |
554,207
+14,997
| +3% | +$3.42M |
|
470
RH
RH
$4.7B
| $126M | 0.02% |
475,296
+447,164
| +1,590% | +$118M |
|
471
Packaging Corp of America
PKG
$19.8B
| $125M | 0.02% |
815,387
-29,320
| -3% | -$4.5M |
|
472
Agilon Health
AGL
$497M
| $123M | 0.02% |
6,944,799
+3,053,102
| +78% | +$54.2M |
|
473
Vaxcyte
PCVX
$4.29B
| $123M | 0.02% |
2,417,652
+225,270
| +10% | +$11.5M |
|
474
CoStar Group
CSGP
$37.9B
| $122M | 0.02% |
1,588,978
-1,254,986
| -44% | -$96.5M |
|
475
Eaton
ETN
$136B
| $122M | 0.02% |
572,673
-5,152,317
| -90% | -$1.1B |
|